EZH2 Antikörper (AA 1-250)
-
- Target Alle EZH2 Antikörper anzeigen
- EZH2 (Enhancer of Zeste Homolog 2 (EZH2))
-
Bindungsspezifität
- AA 1-250
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EZH2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF)
- Sequenz
- MGQTGKKSEK GPVCWRKRVK SEYMRLRQLK RFRRADEVKS MFSSNRQKIL ERTEILNQEW KQRRIQPVHI LTSVSSLRGT RECSVTSDLD FPTQVIPLKT LNAVASVPIM YSWSPLQQNF MVEDETVLHN IPYMGDEVLD QDGTFIEELI KNYDGKVHGD RECGFINDEI FVELVNALGQ YNDDDDDDDG DDPEEREEKQ KDLEDHRDDK ESRPPRKFPS DKIFEAISSM FPDKGTAEEL KEKYKELTEQ
- Kreuzreaktivität
- Human, Maus, Ratte
- Produktmerkmale
- Polyclonal Antibodies
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-250 of human EZH2/KMT6 (NP_001190176.1).
- Isotyp
- IgG
- Top Product
- Discover our top product EZH2 Primärantikörper
-
-
- Applikationshinweise
- WB,1:500 - 1:2000,IF,1:50 - 1:200
- Kommentare
-
HIGH QUALITY
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
Iron chelation inhibits cancer cell growth and modulates global histone methylation status in colorectal cancer." in: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, Vol. 31, Issue 5, pp. 797-805, (2018) (PubMed).
: "
-
Iron chelation inhibits cancer cell growth and modulates global histone methylation status in colorectal cancer." in: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, Vol. 31, Issue 5, pp. 797-805, (2018) (PubMed).
-
- Target
- EZH2 (Enhancer of Zeste Homolog 2 (EZH2))
- Andere Bezeichnung
- EZH2 (EZH2 Produkte)
- Synonyme
- ENX-1 antikoerper, ENX1 antikoerper, EZH1 antikoerper, EZH2b antikoerper, KMT6 antikoerper, KMT6A antikoerper, WVS antikoerper, WVS2 antikoerper, eya2 antikoerper, im:7149338 antikoerper, zgc:136376 antikoerper, zgc:152758 antikoerper, EZH2 antikoerper, enx-1 antikoerper, enx1 antikoerper, ezh1 antikoerper, kmt6 antikoerper, xez antikoerper, Enx-1 antikoerper, Enx1h antikoerper, mKIAA4065 antikoerper, ezh2 antikoerper, olezh2 antikoerper, enhancer of zeste 2 polycomb repressive complex 2 subunit antikoerper, enhancer of zeste 2 polycomb repressive complex 2 subunit L homeolog antikoerper, enhancer of zeste 2 polycomb repressive complex 2 subunit S homeolog antikoerper, EZH2 antikoerper, ezh2 antikoerper, Ezh2 antikoerper, ezh2.L antikoerper, ezh2.S antikoerper
- Hintergrund
- This gene encodes a member of the Polycomb-group (PcG) family. PcG family members form multimeric protein complexes, which are involved in maintaining the transcriptional repressive state of genes over successive cell generations. This protein associates with the embryonic ectoderm development protein, the VAV1 oncoprotein, and the X-linked nuclear protein. This protein may play a role in the hematopoietic and central nervous systems. Multiple alternatively splcied transcript variants encoding distinct isoforms have been identified for this gene.,ENX-1,ENX1,EZH1,EZH2b,KMT6,KMT6A,WVS,WVS2,EZH2,KMT6 / EZH2,Epigenetics & Nuclear Signaling,Chromatin Modifying Enzymes,Methylation,Chromatin Remodeling,Cancer,Tumor biomarkers,EZH2
- Molekulargewicht
- 79 kDa/81 kDa/84 kDa/85 kDa/86 kDa
- Gen-ID
- 2146
- UniProt
- Q15910
- Pathways
- Retinoic Acid Receptor Signaling Pathway, Regulation of Muscle Cell Differentiation
-